๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Group motivational enhancement therapy as an adjunct to inpatient treatment for eating disorders: a preliminary study

โœ Scribed by Helen Y. Dean; Stephen W. Touyz; Elizabeth Rieger; Christopher E. Thornton


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
138 KB
Volume
16
Category
Article
ISSN
1072-4133

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Difficulties in fostering eating disorder (ED) patients' motivations to overcome their illness are widely considered to be a major hurdle in the course of successful treatment. However, no previous study has assessed the use of interventions specifically designed to target poor motivation amongst patients with illnesses that are severe enough to warrant hospitalisation.

Objective

A brief Motivational Enhancement Therapy (MET) group programme for inpatient ED sufferers was developed and evaluated.

Method

Forty two consecutive inpatients were sequentially allocated to treatment groups. Twenty three inpatients completed a four session MET group programme in addition to routine hospital care. A control group of 19 participants completed treatment as usual (TAU).

Results

Despite an absence of significant differences between the MET and the TAU groups on the overall formal outcome measures, there were nevertheless differences between the groups. Specifically, the MET groups appeared to foster longer term motivation and engagement, and to promote treatment continuation.

Conclusion

The results tentatively suggest that MET could be valuable for the treatment of inpatient eating disorder patients and further research is warranted. Copyright ยฉ 2007 John Wiley & Sons, Ltd and Eating Disorders Association.


๐Ÿ“œ SIMILAR VOLUMES


Adacolumn for selective leukocytapheresi
โœ Abbi R. Saniabadi; Hiroyuki Hanai; Yasuo Suzuki; Toshihide Ohmori; Koji Sawada; ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 661 KB

Inflammatory and/or autoimmune diseases like ulcerative colitis (UC) or Crohn's disease (CD) are debilitating chronic disorders that poorly respond to pharmacological interventions. Further, drug therapy has adverse effects that add to disease complications. The current thinking is that disorders li